[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"updates-archive-2026-03-27-1":3},{"date":4,"filings":5,"has_more":14,"limit":15,"page":16,"total_count":16},"2026-03-27",[6],{"company_name":7,"filing_date":8,"filing_source":9,"headline":10,"id":11,"stock_code":12,"summary_text":13},"BALAXI PHARMACEUTICALS LIMITED","2026-03-27T01:05:51.856000","NSE","Trading Window Closure Announced","69c58ac73b41300152f3a318","BALAXI","*   The trading window for designated persons and their relatives will be closed from **April 01, 2026**.\n*   This is in preparation for the announcement of Audited Financial Results for the fourth quarter and financial year ending March 31, 2026.\n*   The trading window will reopen **48 hours after the declaration of the financial results**.\n*   This is a standard compliance filing to prevent insider trading ahead of the results announcement.",false,100,1]